Additionally, they may contribute to therapy resistance and are linked to the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) signaling pathway, which is known to be activated in cancer to promote cancer progression [9,10,11,12,13]. The gene discussed is AKT1; the disease is cancer.